JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth-Reference-Cited by-同舟云学术

JAK Kinase Inhibition Abrogates STAT3 Activation and Head and Neck Squamous Cell Carcinoma Tumor Growth

Published:2015-03 Issue:3 Volume:17 Page:256-264
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Sen Malabika,Pollock Netanya I.,Black John,DeGrave Kara A.,Wheeler Sarah,Freilino Maria L.,Joyce Sonali,Lui Vivian W.Y.,Zeng Yan,Chiosea Simion I.,Grandis Jennifer R.

Publisher

Elsevier BV

Subject

Cancer Research

Reference36 articles.

1. Regulation of JAK-STAT signalling in the immune system;Shuai;Nat Rev Immunol,2003

2. Targeting the interleukin-6/Jak/stat pathway in human malignancies;Sansone;J Clin Oncol,2012

3. Therapeutic suppression of constitutive and inducible JAK\STAT activation in head and neck squamous cell carcinoma;Kupferman;J Exp Ther Oncol,2009

4. JAK/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapies;Jatiani;Genes Cancer,2010

5. Pharmaceutical intervention in the JAK/STAT signaling pathway;Seidel;Oncogene,2000

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targeting of siRNA/anti-cancer drug delivery system for non-melanoma skin cancer. Part I: Development and gene silencing of JAK1siRNA/5-FU loaded liposome nanocomplexes;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Head and neck cancer: pathogenesis and targeted therapy;MedComm;2024-08-21

3. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors;OncoImmunology;2024-07-18

4. Crosstalk between CAFs and tumour cells in head and neck cancer;Cell Death Discovery;2024-06-26

5. Molecular pathways and targeted therapies in head and neck cancers pathogenesis;Frontiers in Oncology;2024-06-17